Prostate Cancer Treatment Trifecta
Trifecta Approach Important in Prostate Cancer Treatment
With over 5,600 successful surgeries and counting, Dr. David B. Samadi, MD, aims high when it comes to prostate cancer
Three is a very important number to Dr. David Samadi, Chairman of Urology, Chief of Robotic Surgery at Lenox Hill Hospital, and Professor of Urology at Hofstra North Shore-LIJ School of Medicine. Considered a mystical number, Samadi has incorporated this number in his robotic prostatectomy practice. Having performed over 5,600 successful prostate cancer treatments in his work, Samadi’s experience is unparalleled.
Thanks to three fellowships, he is not only an accomplished robotic surgeon, he is also expertly trained in open and laparoscopic surgery. Samadi refers to himself as "three surgeons in one head,” which is crucial in surgery, if he needed to switch from one type of surgery to another.
Prostate Cancer Treatment Options
When determining prostate cancer treatment for his patients, Dr. Samadi uses a three-pronged approach, taking into consideration:
- Prostate specific antigen (PSA) level
- Digital rectal exam (DRE)
- Gleason scores
This information is used as a baseline monitor, along with other risk factors such as lifestyle and family history, to help successfully treat this disease.
Currently, the most popular treatment options for prostate cancer are:
- Active surveillance
uses high-energy rays or seeds to kill cancer cells. It is ideal for low-grade, prostate-confined cancer and recurrent cancer cases.
2. Active surveillance
, also known as “watchful waiting
,” means waiting until the cancer exhibits symptoms before starting treatment. It may also mean closely monitoring the patient’s tests, exams and ultrasounds to determine the cancer’s growth.
. The third option is a radical prostatectomy
, whereby the entire prostate gland is removed, which can be done traditionally (via open surgery), laparoscopically, or robotically
In choosing a treatment, Dr. Samadi stands behind the viability of a radical prostatectomy. It is, in Samadi’s opinion, the “gold standard
” for completely eliminating prostate cancer that is organ-confined
. Understandably, he advocates a robotic prostatectomy, via the da Vinci robot
, as the most effective way of treating prostate cancer
. “It is only by removing the prostate that I can ascertain three things: if the cancer is organ-contained, the type of cancer, and the stage of the cancer,” explained Samadi.
The “Triple Play” Philosophy For Prostate Cancer Treatment
In keeping with his “triple play philosophy,” Dr. Samadi believes that with his experience in open prostate surgery and laparoscopic prostatectomy, robotic prostate surgery can offer his patients the best cure
(with post-operative long-term PSA levels undetectable), retention of sexual function
, and continence
(see chart below). “All three factors are equally important to my patients, and my experience with robotic surgery has consistently provided these to them,” continued Samadi.
Dr. Samadi envisions promising advancements in the arena of prostate cancer research. He cites the possibility of gene therapy, whereby prostate cancer cells are infected with genes that prevent them from multiplying. Another hopeful treatment includes immunotherapy, which stimulates the body’s own immune system to attack cancer cells. And finally, there are many potential vaccines being researched to prevent prostate cancer from developing in the first place.
“Choosing robotic surgery is a no-brainer. Choosing the right surgeon who performs a large volume of these cases and is also a trained oncologist is most important
,” says Dr. Samadi, “I have increased visibility, magnification, and dexterity with no tremors. The patient’s time in surgery is reduced to 1-2 hours.
The incisions are smaller, with minimal blood loss. They are discharged within 24 hours. Recovery is faster and side effects are practically eliminated.
” Samadi is confident in his trifecta approach to prostate cancer and robotic surgery as the most effective treatment option available.
David B. Samadi, M.D
Chairman of Urology, Chief of Robotic Surgery at Lenox Hill Hospital, and Professor of Urology at Hofstra North Shore-LIJ School of Medicine
Over 5,600 Prostate Surgeries Performed to Date
Dr. Samadi is one of the very few urologic surgeons in the United States trained in oncology, open, laparoscopic, and robotic surgery. He is also the first surgeon in the United States to successfully perform a robotic surgery redo. To date, Dr. Samadi has performed over 5,600 prostate surgeries. This is more than any other prostate cancer surgeon in all of New York.
Make an appointment: 1-212-365-5000†
Ron S., USA
Dr. Samadi, you are obviously a masterful surgeon. In addition to your individual talents, you are also a tremendous CEO.
V. Sanchez, Spain
After 24 hours of my operation, I was discharged. After 7 days, I removed the catheter and, within 12 days, I returned to my country. On the same day I removed my catheter, I was able to walk for an hour. The incontinence diminishes more each day and, at this rate, I hope that in two or three weeks, it will be one hundred percent under control. Sexual function shows signs of full recovery without any drugs.
Little Johnny Rivero, USA
PROSTATE CANCER! How could it be? Iím young and have had annual PSA tests to monitor my prostate cancer risk. I only recently began to experience sharp pain in my lower back but I knew I had to seek treatment.
Dr. M. Ritch, Kingston, Jamaica, West Indies
I must commend you on your excellent staff and your nurses, which offers patients pre and post operative advice as well as much more information. Not all patients will qualify for robotic prostatectomy but, for those who do, I highly recommend them to seek your advice and approach surgery without fear as your expertise in this area is unparalleled.
I chose to undergo the operation with a specialist in the U.S., who has an extensive experience in robotic surgeries: Dr. David Smadi. The surgery was relatively simple: i didn't suffer any pain, lost a small amount of blood and had the catheter only for seven days. I got back to full functioning very soon afterwards.
הסיפור שלי מתחיל בספטמבר 2010, כשתוצאות בדיקותיי היו: PSA -4.9, גליסון- 6 (3+3). יש לציין שסבלתי שנים ממתן שתן איטי של בן דקה לדקה וחצי, שזהו מדד לערמונית מוגדלת. במהלך החודשים שלאחר מכן ניגשתי לארבע בדיקות PSA נוספות שהצביעו על עליה ברורה, למעט ירידה אחת באמצע .( 5.22, 4.96, 5.76, 6.16 )
T. Civetta, Italy
Nel mese di ottobre 2008 mi è stato dignosticato un tumore alla prostata. All'età di 43 anni non è facile gestire una notizia di questo tipo, sia sul piano fisico che sul piano psicologico. Mi sono rivolto al dottor David Samadi e dal momento che sono entrato nel suo ufficio, subito ho capito, grazie alla sua positivita` sicurezza e professionalita`, che ero nelle mani giuste.